Advertisement

Topics

A Surprising Amount of Medical Research Isn’t Made Public. That’s Dangerous.

14:51 EDT 1 Aug 2017 | Bioethics.com

(Vox) – When the results of clinical trials aren’t made public, the consequences can be dangerous — and potentially deadly. Consider the case of the anti-depressant Paxil, produced by the drug company SmithKline Beecham (now part of GlaxoSmithKline). GSK got … Read More

Original Article: A Surprising Amount of Medical Research Isn’t Made Public. That’s Dangerous.

NEXT ARTICLE

More From BioPortfolio on "A Surprising Amount of Medical Research Isn’t Made Public. That’s Dangerous."

Quick Search
Advertisement
 

Relevant Topics

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...